We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
MetrioPharm AG, a pharmaceutical company developing drugs for chronic inflammatory diseases, has been nominated to receive funding under the HERA Incubator from the European Commission under Grant Agreement number 101046182.